These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26323866)

  • 1. Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy.
    Chung YW; Yang YH; Wu CK; Yu CC; Juang JM; Wang YC; Tsai CT; Lin LY; Lai LP; Hwang JJ; Chiang FT; Chen PC; Lin JL
    Int J Cardiol; 2016 Jan; 202():962-6. PubMed ID: 26323866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease.
    Ho LT; Lin LY; Yang YH; Wu CK; Juang JM; Wang YC; Tsai CT; Lai LP; Hwang JJ; Chiang FT; Lin JL; Chen PC
    Int J Cardiol; 2015 Dec; 201():538-43. PubMed ID: 26322603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.
    Lin TT; Yang YH; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY
    Kidney Int; 2015 Aug; 88(2):378-85. PubMed ID: 25807037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis.
    Lin TT; Chiang JY; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Lin JL; Lin LY
    Sci Rep; 2015 Dec; 5():17731. PubMed ID: 26643783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy.
    Liao JN; Chao TF; Liu CJ; Wang KL; Chen SJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chen TJ; Chen SA
    Kidney Int; 2015 Jun; 87(6):1209-15. PubMed ID: 25587708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-platelet or anti-coagulant agent for the prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation--a nation-wide database analyses.
    Chen JJ; Lin LY; Yang YH; Hwang JJ; Chen PC; Lin JL
    Int J Cardiol; 2014 Dec; 177(3):1008-11. PubMed ID: 25449515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.
    Köbe J; Wasmer K; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Klein HU; Eckardt L
    Int J Cardiol; 2013 Oct; 168(4):4184-90. PubMed ID: 23948108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.
    Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K
    Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients.
    Buiten MS; de Bie MK; Rotmans JI; Gabreëls BA; van Dorp W; Wolterbeek R; Trines SA; Schalij MJ; Jukema JW; Rabelink TJ; van Erven L
    Heart; 2014 May; 100(9):685-90. PubMed ID: 24670418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan.
    Chao TF; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Wu TJ; Chen TJ; Chen SA
    Int J Cardiol; 2013 Sep; 168(2):1360-3. PubMed ID: 23280330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.
    Wang CC; Lin CL; Wang GJ; Chang CT; Sung FC; Kao CH
    Thromb Haemost; 2015 Jan; 113(1):185-92. PubMed ID: 25318828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Hyperglycemic Agents and New-Onset Acute Myocardial Infarction in Diabetic Patients with End-Stage Renal Disease Undergoing Dialysis.
    Lin TT; Wu CC; Yang YH; Lin LY; Lin JL; Chen PC; Hwang JJ
    PLoS One; 2016; 11(8):e0160436. PubMed ID: 27513562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation.
    Spivey CA; Qiao Y; Liu X; Mardekian J; Parker RB; Phatak H; Claflin AB; Kachroo S; Abdulsattar Y; Chakrabarti A; Wang J
    J Manag Care Spec Pharm; 2015 Jul; 21(7):596-606. PubMed ID: 26108384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
    Shih CJ; Ou SM; Chao PW; Kuo SC; Lee YJ; Yang CY; Tarng DC; Lin CC; Huang PH; Li SY; Chen YT
    Circulation; 2016 Jan; 133(3):265-72. PubMed ID: 26680239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of spironolactone in the metabolism of serum type I collagen in elderly patients with atrial fibrillation.
    Zhang SH; Wang J; Jin TR; Zhang LX; Shao J
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2903-7. PubMed ID: 25339485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene.
    Huang WF; Tsai YW; Wen YW; Hsiao FY; Kuo KN; Tsai CR
    Menopause; 2010; 17(1):57-63. PubMed ID: 19680161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation associated hospitalizations in patients with end-stage renal disease in the United States, 2003-2012.
    Kumar N; Khera R; Garg N
    Heart Rhythm; 2016 Oct; 13(10):2027-33. PubMed ID: 27374238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation-- a nation wide database analysis.
    Lin LY; Lee CH; Yu CC; Tsai CT; Lai LP; Hwang JJ; Chen PC; Lin JL
    Atherosclerosis; 2011 Jul; 217(1):292-5. PubMed ID: 21513938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.